期刊文献+

维持性血液透析患者隐匿性乙型肝炎病毒感染的调查与分析 被引量:9

Prevalence of occult hepatitis B virus infection in maintenance hemodialysis patients
下载PDF
导出
摘要 目的:旨在评估维持性血液透析(MHD)患者中隐匿性乙型肝炎病毒(HBV)感染(OBI)情况。方法:对2014年12月至2015年12月四川省人民医院血液透析中心的MHD患者采用ELISA法检测HBV标记物,并对HBs Ag(-)/HBc Ab(+)患者进行实时定量荧光PCR(real-time PCR)检测HBV-DNA,了解OBI的患病率。结果:(1)入选本中心MHD患者330例,平均年龄60.66±14.32岁,男性55.7%,女性44.3%;HBV患病率为7.3%(24/330),54.5%(180/330)为既往感染过HBV[HBs Ag(-)/HBc Ab(+)];(2)共收集到165例既往感染过HBV患者的血浆标本进行HBV-DNA检测,发现7例阳性,水平均很低(<20 IU/ml),所以OBI的患病率对于进行检测的患者来说为4.2%(7/165),对于整个透析中心患者来说为2.2%(7/315);(3)将7例OBI患者作为观察组,剩下158例HBV-DNA(-)患者作为对照组进行比较发现,男性OBI比例更高(P=0.042),疫苗接种可预防OBI(P=0.010);(4)单一HBc Ab(+)患者(6.5%)比HBc Ab(+)/HBs Ab(+)患者(3.8%)具有更高的OBI患病率,但两者间无明显统计学差异(P=0.617)。结论:本组MHD患者中54.5%既往感染过HBV,目前OBI患病率为2.2%,且HBV-DNA水平低下,但仍有引起病毒传播的风险,特别是单一HBc Ab(+)患者。 Objective: To investigate the prevalence of occult hepatitis B virus( HBV) infection( OBI) in maintenance hemodialysis( MHD) patients. Methodology: MHD patients in our dialysis units from December 2014 to December 2015 were enrolled. HBV marker was examined by ELISA. The sera from HBc Ab( +)/HBs Ag(-) individuals were tested for HBV-DNA by a real-time quantitative PCR to investigate the prevalence of OBI. Results:( 1) They were three hundred and thirty patients,55. 7% were male and 44. 3% were female with a mean age of 60. 7 ± 14. 3 years. 24( 7. 3%) patients had chronic HBV infection( HBs Ag positive). 180( 54. 5%) patients were HBc Ab( +)/HBs Ag(-)which suggested past infection.( 2) Plasma samples of 165 patients with past HBV infection were obtained for HBV-DNA detection. Elevated HBV-DNA level( 〈20 IU/ml) was detected in 7( 4. 2%) patients,therefore the prevalence of OBI was2. 2%( 7/315) in all the dialysis patients.( 3) Comparing the 7 patients with OBI,it was found that male were more prone to OBI( P = 0. 042),and vaccination may be effective in preventing OBI( P = 0. 010) in the 158 patients who were HBVDNA negative.( 4) The prevalence of OBI in HBc Ab( +)/HBs Ab(-) patients( 6. 5%) was higher than that in HBc Ab( +)/HBs Ab( +) patients( 3. 8%),but the difference was not significant( P = 0. 617). Conclusion: 54. 5% of MHD patients in our center had evidence of past HBV infection,and the prevalence of OBI was 2. 2% with very low level of HBV-DNA. However,there may be a potential risk that the patients with OBI may transmit infection within dialysis units,especially when the patient was HBc Ab( +)/HBs Ab(-).
出处 《肾脏病与透析肾移植杂志》 CSCD 北大核心 2017年第5期438-441,456,共5页 Chinese Journal of Nephrology,Dialysis & Transplantation
基金 中国医院协会课题(CHABP2016-12)
关键词 维持性血液透析 隐匿性乙型肝炎病毒感染 乙型肝炎病毒-DNA maintenance hemodialysis occult hepatitis B virus infection hepatitis B virus DNA
  • 相关文献

参考文献2

二级参考文献27

  • 1[1]Hu KQ.Occult hepatitis B virus infection and its clinical implications.J Viral Hepat 2002; 9:243-257
  • 2[2]Marrero JA,Lok AS.Occult hepatitis B virus infection in patients with hepatocellular carcinoma:Innocent bystander,cofactor,or culprit? Gastroenterology 2004; 126:347-350
  • 3[3]Allain JP.Occult hepatitis B virus infection:implications in transfusion.Vox Sang 2004; 86:83-91
  • 4[4]Allain JP.Occult hepatitis B virus infection.Transfus Clin Biol 2004; 11:18-25
  • 5[5]Toyoda H,Hayashi K,Murakami Y,Honda T,Katano Y,Nakano I,Goto H,Kumada T,Takamatsu J.Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan.JMed Virol 2004; 73:195-199
  • 6[6]Oesterreicher C,Hammer J,Koch U,Pfeffel F,Sunder-Plassmann G,Petermann D,Muller C.HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis.Kidney Int 1995; 48:1967-1971
  • 7[7]Torbenson M,Kannangai R,Astemborski J,Strathdee SA,Vlahov D,Thomas DL.High prevalence of occult hepatitis B in Baltimore injection drug users.Hepatology 2004; 39:51-57
  • 8[8]Shire NJ,Rouster SD,Rajicic N,Sherman KE.Occult hepatitis B in HIV-infected patients.J Acquir Immune Defic Syndr 2004;36:869-875
  • 9[9]Khan MH,Farrell GC,Byth K,Lin R,Weltman M,George J,Samarasinghe D,Kench J,Kaba S,Crewe E,Liddle C.Which patients with hepatitis C develop liver complications? Hepatology 2000; 31:513-520
  • 10[10]Fukuda R,Ishimura N,Niigaki M,Hamamoto S,Satoh S,Tanaka S,Kushiyama Y,Uchida Y,Ihihara S,Akagi S,Watanabe M,Kinoshita Y.Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease:clinical and virological significance.J Med Virol 1999;58:201-207

共引文献12

同被引文献84

引证文献9

二级引证文献161

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部